Results 121 to 130 of about 2,687 (162)

Multifunctional nanoplatform as nano-inducer of ferroptosis for targeted recognition and imaging-guided therapy of metastatic prostate cancer. [PDF]

Mater Today Bio
He L, Liang H, Wang J, Liu A, Li L, Lu J, Wang Z, Whittaker AK, Lin Q.   +8 more
europepmc   +1 more source

Radioligand Therapy in Cancer Management: A Global Perspective. [PDF]

Cancers (Basel)
Ninatti G, Lee ST, Scott AM.
europepmc   +1 more source

First-in-Human Serum Stability Studies of [¹⁷⁷Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy. [PDF]

J Nucl Med
Felber V, Holzleitner N, Joksch M, Suhrbier T, von Amsberg G, Schwarzenböck S, Kurth J, Heuschkel M, Günther T, Krause BJ.   +9 more
europepmc   +1 more source

Evolution of the Jawed Vertebrate (Gnathostomata) Stomach Through Gene Repertoire Loss: Findings from Agastric Species. [PDF]

J Dev Biol
Dann J, Grützner F.
europepmc   +1 more source

The neuro-immune insights of itch: peripheral mechanisms and central glial contributions. [PDF]

Cell Mol Biol Lett
Li Z, Yu N, Feng S, Wang X, Chu YX, Liu X.   +5 more
europepmc   +1 more source

Development of Novel Gastrin-Releasing Peptide Receptor-Targeted Radioligand with Albumin Binder to Improve Accumulation in Tumor. [PDF]

ACS Med Chem Lett
Tsuchihashi S, Nakashima K, Watanabe H, Ono M.   +3 more
europepmc   +1 more source

In vitro gastrin-releasing peptide response in chicken ovarian follicles. [PDF]

Poult Sci
Mo C, Lv C, Zhu G, Zhang J, Li Y, Wang Y, Li J.   +6 more
europepmc   +1 more source

The Role of Nuclear Medicine in Prostate Cancer. [PDF]

Diagnostics (Basel)
Grozdic Milojevic I, Milojevic B, Skrijelj D, Bumbasirevic U, Janicic A, Kajmakovic B, Sobic-Saranovic D, Artiko V, Beatovic S.   +8 more
europepmc   +1 more source

NOTA and NODAGA Radionuclide Complexing Agents: Versatile Approaches for Advancements in Radiochemistry. [PDF]

Molecules
Chambers CG, Wang J, Sakr TM, Miao Y, Smith CJ.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals

Nuklearmedizin - NuclearMedicine, 2022
AbstractAddressing molecular targets, that are overexpressed by various tumor entities, using radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is of increasing interest in oncology. The gastrin-releasing peptide receptor (GRPr), which is part of the bombesin family, has shown to be overexpressed in a variety of ...
Jens, Kurth, Madlin, Potratz, Martin, Heuschkel, Bernd J, Krause, Sarah Marie, Schwarzenböck   +4 more
openaire   +2 more sources